Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Ginkgo Bioworks Holdings, Inc. (DNA) had Receiveable Turnover of 14.05 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$251.46M |
|
$-892.87M |
|
$54.01M |
|
$197.45M |
|
$1.12B |
|
$-864.41M |
|
$-28.53M |
|
$-892.94M |
|
$-838.11M |
|
$-892.87M |
|
$-892.87M |
|
$-892.87M |
|
$-838.04M |
|
$-864.41M |
|
$-792.85M |
|
1.94B |
|
1.94B |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$1.00B |
|
$188.19M |
|
$663.59M |
|
$1.67B |
|
$163.86M |
|
-- |
|
$404.33M |
|
$568.19M |
|
$1.10B |
|
$965.17M |
|
$1.10B |
|
2.00B |
|
| Cash Flow Statement Financials | |
$-295.50M |
|
$-80.69M |
|
$-3.22M |
|
$1.37B |
|
$989.58M |
|
$-380.00M |
|
$229.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
78.52% |
|
-343.76% |
|
-343.76% |
|
-315.31% |
|
-355.11% |
|
-355.08% |
|
$-331.87M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
|
Receiveable Turnover |
14.05 |
25.98 |
|
-81.38% |
|
-92.51% |
|
-53.61% |
|
-81.38% |
|
$0.55 |
|
$-0.17 |
|
$-0.15 |
|